Sort
130,381 grants matching “hiv”
Effect of opioid use disorder on HIV latent reservoirs and immune dysfunction assessed by single-cell transcriptomics
$951,284Christine Cheng · Boston University (Charles River Campus) · R61 · FY2020 · DA
Do Early Maternal Antibodies Facilitate Oral Transmission of HIV in Infants?
$951,220Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2014 · DE
Northeast Node of the National Drug Abuse Clinical Trials Network
$951,169Lisa A Marsch · Dartmouth College · UG1 · FY2019 · DA
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes
$951,169Jeffrey David Klausner · University Of Southern California · R01 · FY2022 · AI
Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.
$951,144Francis W. Ruscetti · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers
$950,999Jeffrey N Martin · University Of California, San Francisco · U54 · FY2023 · CA
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$950,729Jonah B. Sacha · Oregon Health & Science University · R01 · FY2021 · AI
INTERNET HIV PREVENTION TECHNOLOGY TRANSFER + WORLD NGOS
$950,716Medical College Of Wisconsin · R01 · FY2002 · MH
A Novel, Logical Approach to HIV Vaccine Development
$950,584David I Watkins · University Of Wisconsin-Madison · R01 · FY2006 · AI
Inducing HIV-1 NAb Breadth by Native Trimer Prime-Boost Vaccination
$950,504James M Binley · San Diego Biomedical Research Institute · R01 · FY2021 · AI
Genetics and Progression of Early-onset Substance Dependence and HIV Risk
$950,463Christian J Hopfer · University Of Colorado Denver · R01 · FY2015 · DA
Point-of-care HIV viral load system using RPA and MXR
$950,372Jay Kenneth Fisher · Redbud Labs, Inc. · R44 · FY2023 · MH
Host and viral genomic determinants of HIV latent reservoir size and characteristics in individuals with substance use disorders
$950,298Robert F Siliciano · Johns Hopkins University · R61 · FY2018 · DA
Human Dendritic Cell Subsets
$950,220Jacques F Banchereau · Baylor Research Institute · U19 · FY2008 · AI
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
$950,109Wendy S Post · Johns Hopkins University · R01 · FY2010 · HL
Preclinical Development of MucoCept
$950,073Craig R Cohen · University Of California, San Francisco · U01 · FY2016 · AI
Identification and characterization of chromatin regulators of HIV-1 latency
$950,000Susana T Valente · Scripps Florida · R61 · FY2019 · AI
NYC DOHMH BHIV CAPACITY BLDG FOR HIGH IMPACT HIV PREVENTION
$950,000Graham Harriman · New York City Health/Mental Hygiene · U65 · FY2015 · PS
PREVENTION OF MOTHER TO CHILD TRANSMISSION OF HIV (PMTCT) & PEDIATRIC HIV CARE IN
$950,000Nilda R Lambo · Unicef Zambia · U2G · FY2010 · PS
NIAID DCR OPERATIONAL TASK ORDERCOVID FUNDING SUPPORTS THE NIAID DCR COVID WEBSITE AND THE VARIANT TESTING SAVE PROGRAM FOR VARIANT TESTING.
$950,000Barry Gause · Leidos Biomedical Research, Inc. · N01 · FY2021 · AI
HIV Vaccine Research and Development â NeuroHIV studies
$950,000Julie Ake · National Institute Of Allergy And Infectious Diseases · Y01 · FY2022 · AI
HIV Vaccine Research and Development - Central Nervous System Studies
$950,000Julie Ake · National Institute Of Allergy And Infectious Diseases · Y01 · FY2020 · AI
HIV Vaccine Research and Development - Central Nervous System Studies
$950,000Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases · Y01 · FY2018 · AI
Identification and characterization of chromatin regulators of HIV-1 latency
$950,000Susana T Valente · Scripps Florida · R61 · FY2018 · AI
HIV Vaccine Research and Development â NeuroHIV studies
$950,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2023 · AI